Tag: Novartis

All

Novartis' Cosentyx is the first approved human monoclonal antibody that selectively binds to interleukin IL-17A.

The tablet- and smartphone-based tool allows plastic surgeons to generate personalized 3D visualizations during breast augmentation consultations.